NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis

NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis
Inverse relationship between ETV7 and SERPINE1 in OSCC. (A) Representative immunostaining for ETV7 (red) in SJG26 and SJG6 tumour biopsies with DAPI counterstain (blue). Scale bar: 200 μm. (B) Quantification of mean nuclear ETV7 staining in OSCC tumour biopsies. Note lower % ETV7 positive cells in NOTCH1 mutant tumour (SJG6) compared to NOTCH1 wild type (SJG26). Multiple t-test, *p < 0.05. (C) Representative immunostaining for SERPINE1 (green) in SJG26 and SJG6 tumour biopsies with DAPI counterstain (blue). Scale bar: 200 μm. (D) Quantification of staining intensities for NOTCH1, ETV7 and SERPINE1 in SJG6 (NOTCH1 mutant) and SJG26 (NOTCH1 WT) tumour biopsies. One sample t-test was used. *p < 0.05; **p < 0.01; ****p < 0.0001. (E) Schematic of the NOTCH1/ETV7/SERPINE1 regulatory axis. (B, D) Data represent mean ± SD. Credit: Fiona M. Watt - Fiona.watt@kcl.ac.uk

In this study, the research team investigated NOTCH1 mutations in keratinocyte lines derived from OSCC biopsies that had been subjected to whole exome sequencing.

One line, SJG6, was found to have truncating mutations in both NOTCH1 alleles, resulting in loss of NOTCH1 expression.

Overexpression of the NOTCH1 intracellular domain in SJG6 promoted and differentiation, while suppressing proliferation, migration and clonal growth, consistent with the previously reported tumour suppressive function of NOTCH1 in OSCC.

Dr. Fiona M. Watt from the Centre for Stem Cells and Regenerative Medicine, King's College London; Tower Wing, Guy's Hospital, London, UK said "Notch1 is a heterodimeric and multifunctional transmembrane receptor that regulates key cellular processes, including cell fate determination, maintenance of , cell survival, proliferation and apoptosis."

Notch1 is a heterodimeric and multifunctional transmembrane receptor that regulates key cellular processes, including cell fate determination, maintenance of stem cells, cell survival, proliferation and apoptosis.

The majority of NOTCH1 mutations occur in the EGF-like ligand binding domain of the NECD, and prevent ligand binding and downstream signaling.

The detection of NOTCH1 mutations in dysplastic regions, and reduced expression of NOTCH1 in pre-neoplastic and cancerous skin lesions, suggests its potential gate-keeper properties.

Some studies have implicated Notch1 signaling in angiogenesis and in HNSCC, while in vitro studies have pointed to the role of NOTCH1 in promoting keratinocyte differentiation.

The Watt Research Team concluded that their study indicates that the tumour suppressive role of NOTCH1 in OSCC is manifested, at least in part, by ETV7-mediated suppression of SERPINE1.


Explore further

Blood flow–sensing protein protects against atherosclerosis in mice

More information: Salameti, et al. NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis, Oncotarget (2019). DOI: 10.18632/oncotarget.27306
Journal information: Oncotarget

Provided by Impact Journals LLC
Citation: NOTCH1 signaling in oral squamous cell carcinoma via a TEL2/SERPINE1 axis (2019, December 4) retrieved 27 January 2020 from https://medicalxpress.com/news/2019-12-notch1-oral-squamous-cell-carcinoma.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments